Yan‐yan Yan

808 total citations
14 papers, 655 citations indexed

About

Yan‐yan Yan is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Yan‐yan Yan has authored 14 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Yan‐yan Yan's work include Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (5 papers) and HIV/AIDS drug development and treatment (3 papers). Yan‐yan Yan is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Cancer therapeutics and mechanisms (5 papers) and HIV/AIDS drug development and treatment (3 papers). Yan‐yan Yan collaborates with scholars based in China, Hong Kong and United States. Yan‐yan Yan's co-authors include Liwu Fu, Yong‐ju Liang, Chun-ling Dai, Jianye Zhang, Fang Wang, Zhi‐Gang She, Liming Chen, Zhe‐Sheng Chen, Amit K. Tiwari and Kenneth K.W. To and has published in prestigious journals such as PLoS ONE, European Journal of Cancer and Cancer Letters.

In The Last Decade

Yan‐yan Yan

14 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan‐yan Yan China 13 356 303 91 73 68 14 655
D Mingying China 3 377 1.1× 330 1.1× 107 1.2× 30 0.4× 48 0.7× 5 681
Yue-Li Sun China 10 248 0.7× 230 0.8× 70 0.8× 69 0.9× 33 0.5× 23 535
Indu Sinha United States 14 270 0.8× 145 0.5× 73 0.8× 32 0.4× 36 0.5× 24 751
Judit Cserepes Hungary 7 416 1.2× 472 1.6× 62 0.7× 25 0.3× 82 1.2× 10 786
Xiaomin Zhang China 15 265 0.7× 409 1.3× 72 0.8× 129 1.8× 10 0.1× 52 816
Junko Satoh Japan 19 578 1.6× 94 0.3× 33 0.4× 30 0.4× 66 1.0× 41 1.2k
Zhiling Li China 10 255 0.7× 132 0.4× 75 0.8× 48 0.7× 30 0.4× 25 726
Yuki Nakajima Japan 18 297 0.8× 197 0.7× 40 0.4× 65 0.9× 34 0.5× 79 816
Jeffrey S. Johnston United States 14 302 0.8× 150 0.5× 32 0.4× 25 0.3× 19 0.3× 23 648
Vincent Bertholet Belgium 10 389 1.1× 262 0.9× 95 1.0× 24 0.3× 48 0.7× 13 665

Countries citing papers authored by Yan‐yan Yan

Since Specialization
Citations

This map shows the geographic impact of Yan‐yan Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan‐yan Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan‐yan Yan more than expected).

Fields of papers citing papers by Yan‐yan Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan‐yan Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan‐yan Yan. The network helps show where Yan‐yan Yan may publish in the future.

Co-authorship network of co-authors of Yan‐yan Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Yan‐yan Yan. A scholar is included among the top collaborators of Yan‐yan Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan‐yan Yan. Yan‐yan Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Yan, Yan‐yan, Hong Ji, Hui Wang, et al.. (2021). Microfluidics applications for high-throughput single cell sequencing. Journal of Nanobiotechnology. 19(1). 312–312. 80 indexed citations
2.
Yan, Yan‐yan, et al.. (2021). The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge. Frontiers in Molecular Biosciences. 8. 699929–699929. 26 indexed citations
3.
Wang, Hui, Yun Liu, Hubiao Chen, et al.. (2020). The Role of Exosomal microRNA in Cancer Drug Resistance. Frontiers in Oncology. 10. 472–472. 56 indexed citations
4.
Yan, Yan‐yan, et al.. (2016). Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro. Oncology Reports. 37(1). 31–40. 10 indexed citations
5.
Yan, Yan‐yan, Li-Sheng Zheng, Xu Zhang, et al.. (2011). Blockade of Her2/neu Binding to Hsp90 by Emodin Azide Methyl Anthraquinone Derivative Induces Proteasomal Degradation of Her2/neu. Molecular Pharmaceutics. 8(5). 1687–1697. 45 indexed citations
6.
Wang, Fang, Yong‐ju Liang, Liming Chen, et al.. (2011). Prognostic value of the multidrug resistance transporter ABCG2 gene polymorphisms in Chinese patients with de novo acute leukaemia. European Journal of Cancer. 47(13). 1990–1999. 18 indexed citations
7.
8.
Dai, Chun-ling, Yong‐ju Liang, Amit K. Tiwari, et al.. (2009). Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. Cancer Letters. 279(1). 74–83. 101 indexed citations
9.
Zheng, Li-Sheng, Fang Wang, Yuhong Li, et al.. (2009). Vandetanib (Zactima, ZD6474) Antagonizes ABCC1- and ABCG2-Mediated Multidrug Resistance by Inhibition of Their Transport Function. PLoS ONE. 4(4). e5172–e5172. 75 indexed citations
10.
Zhang, Jianye, Yong‐ju Liang, Yan‐yan Yan, et al.. (2009). Secalonic Acid D induced leukemia cell apoptosis and cell cycle arrest of G1 with involvement of GSK-3β/β-catenin/c-Myc pathway. Cell Cycle. 8(15). 2444–2450. 85 indexed citations
11.
Liang, Yong‐ju, Fang Wang, Liming Chen, et al.. (2009). Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function. Cancer Chemotherapy and Pharmacology. 64(5). 961–969. 44 indexed citations
12.
Chen, Liming, et al.. (2009). Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.. PubMed. 29(11). 4597–604. 21 indexed citations
13.
Liang, Yong‐ju, et al.. (2007). FG020326-loaded nanoparticle with PEG and PDLLA improved pharmacodynamics of reversing multidrug resistance in vitro and in vivo. Acta Pharmacologica Sinica. 28(6). 913–920. 13 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Mingying Breakdown of academic impact, for papers by Yue-Li Sun Breakdown of academic impact, for papers by Indu Sinha Breakdown of academic impact, for papers by Judit Cserepes Breakdown of academic impact, for papers by Xiaomin Zhang Breakdown of academic impact, for papers by Junko Satoh Breakdown of academic impact, for papers by Zhiling Li Breakdown of academic impact, for papers by Yuki Nakajima Breakdown of academic impact, for papers by Jeffrey S. Johnston Breakdown of academic impact, for papers by Vincent Bertholet
Rankless by CCL
2026